Suppression of inducible nitric oxide synthase and cyclooxygenase-2 expression by tussilagone from farfarae flos in BV-2 microglial cells
- Authors
- Lim, Hyo Jin; Lee, Hyun-Sun; Ryu, Jae-Ha
- Issue Date
- May-2008
- Publisher
- PHARMACEUTICAL SOC KOREA
- Keywords
- farfarae flos; tussilagone; nitric oxide; nitric oxide synthase; PGE(2); cyclooxygenase; inhibitor kappaB-alpha
- Citation
- ARCHIVES OF PHARMACAL RESEARCH, v.31, no.5, pp 645 - 652
- Pages
- 8
- Journal Title
- ARCHIVES OF PHARMACAL RESEARCH
- Volume
- 31
- Number
- 5
- Start Page
- 645
- End Page
- 652
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/14275
- DOI
- 10.1007/s12272-001-1207-4
- ISSN
- 0253-6269
1976-3786
- Abstract
- Activated microglia produce diverse neurotoxic factors such as nitric oxide (NO) and prostaglandin E(2) (PGE(2)) that may cause neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. From the EtOAc soluble fraction of Farfarae flos (Tussilago farfara), we purified tussilagone as a bioactive compound by monitoring the inhibitory potential of NO production in activated microglia through the purification procedures. Tussilagone showed dose-dependent inhibition of NO and PGE(2) production in LPS-activated microglia with IC(50) values of 8.67 mu M and 14.1 mu M, respectively. It suppressed the expression of protein and mRNA of inducible nitric oxide synthase and cyclooxygenase-2 through the inhibition of 1-kappa B alpha degradation and nuclear translocation of p65 subunit of NF-kappa B. Therefore tussilagone from Farfarae flos may have therapeutic potential in the treatment of neuro-inflammatory diseases through the inhibition of overproduction of NO and PGE(2).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.